110 related articles for article (PubMed ID: 7352244)
41. Twice-daily radiation therapy for head and neck carcinomas.
Wang CC
Front Radiat Ther Oncol; 1988; 22():93-8. PubMed ID: 3350355
[No Abstract] [Full Text] [Related]
42. Early skin reactions in head and neck malignancy treated by twice-daily fractionated radiotherapy--estimation of alpha/beta of LQ model.
Chougule A; Supe SJ
Phys Med Biol; 1993 Sep; 38(9):1335-42. PubMed ID: 8415904
[TBL] [Abstract][Full Text] [Related]
43. Importance of the time interval between surgery and postoperative radiation therapy in the combined management of head & neck cancer.
Vikram B
Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1837-40. PubMed ID: 528246
[No Abstract] [Full Text] [Related]
44. Overall treatment time and tumor control dose for head and neck tumors: the dog leg revisited.
Bentzen SM; Thames HD
Radiother Oncol; 1992 Oct; 25(2):143-4. PubMed ID: 1438934
[No Abstract] [Full Text] [Related]
45. No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours.
Dubben HH
Radiother Oncol; 1992 Oct; 25(2):142-3. PubMed ID: 1438933
[No Abstract] [Full Text] [Related]
46. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy.
Weichselbaum RR; Beckett MA; Schwartz JL; Dritschilo A
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):575-9. PubMed ID: 3417487
[TBL] [Abstract][Full Text] [Related]
47. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
Bentzen SM; Dische S
Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
[No Abstract] [Full Text] [Related]
48. Radioresistant tumor cell lines derived from head and neck radiation failures.
Weichselbaum RR; Beckett MA; Vijayakumar S; Ahmed-Swan S; Dritschilo A; Schwartz JL; Moran WJ; Goldman ME; Tybor AG; Vokes EE
Head Neck; 1989; 11(4):343-8. PubMed ID: 2753702
[TBL] [Abstract][Full Text] [Related]
49. [Stage, tumor growth rate and optimal dose fractionation schedules in the treatment of squamous cell carcinoma of the head and neck].
Sugawara T; Morita M; Aihara T; Tanaka O
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Mar; 43(3):456-65. PubMed ID: 6889116
[No Abstract] [Full Text] [Related]
50. Dose escalation, treatment protraction, and the steepness of the dose-response curve for squamous cell carcinoma of the head and neck.
Yaes RJ
Radiother Oncol; 1995 Jan; 34(1):81-3. PubMed ID: 7792405
[No Abstract] [Full Text] [Related]
51. Continuous, hyperfractionated, accelerated radiotherapy (CHART).
Dische S
Eur J Cancer; 1990; 26(9):927-8. PubMed ID: 2149016
[No Abstract] [Full Text] [Related]
52. Postoperative irradiation for squamous cell carcinoma of the head and neck.
Vikram B
Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):267-8. PubMed ID: 2298630
[No Abstract] [Full Text] [Related]
53. Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
Fowler JF; Harari PM
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):3-6. PubMed ID: 10924965
[No Abstract] [Full Text] [Related]
54. Radiation therapy in the management of early-stage head and neck cancer.
Hinerman RW; Mendenhall WM; Amdur RJ
Cancer Treat Res; 2003; 114():115-44. PubMed ID: 12619540
[No Abstract] [Full Text] [Related]
55. Late effects after radiotherapy in head and neck malignancies: overall treatment time, number of fractions and the linear-quadratic model.
Huang DT; Lin PS; Schmidt-Ullrich R
Int J Radiat Oncol Biol Phys; 1992; 23(5):1096-7; author reply 1097-8. PubMed ID: 1639649
[No Abstract] [Full Text] [Related]
56. Optimization of uncomplicated control for head and neck tumors.
Agren A; Brahme A; Turesson I
Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):1077-85. PubMed ID: 2211246
[TBL] [Abstract][Full Text] [Related]
57. Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses.
Rosenthal DI; Fuller CD; Peters LJ; Thames HD
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):715-7. PubMed ID: 26104925
[No Abstract] [Full Text] [Related]
58. Radiation-induced changes of fibroblasts in the squamous cell carcinoma of the head and neck.
Kellokumpu-Lehtinen P; Söderström KO; Kortekangas A; Nordman E
Folia Histochem Cytobiol; 1989; 27(3):169-73. PubMed ID: 2612696
[TBL] [Abstract][Full Text] [Related]
59. When is radiation therapy in head and neck squamous cell carcinoma not indicated?
Mendenhall WM; Strojan P; Silver CE; Owen RP; Rinaldo A; Shaha AR; Eisbruch A; Takes RP; Ferlito A
Eur Arch Otorhinolaryngol; 2014 Nov; 271(11):2849-50. PubMed ID: 24141519
[No Abstract] [Full Text] [Related]
60. [Not Available].
Klages HT
Strahlenther Onkol; 2014 Oct; 190(10):970-2. PubMed ID: 25392873
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
